A detailed history of Beta Wealth Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Beta Wealth Group, Inc. holds 5,603 shares of ABT stock, worth $659,809. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,603
Previous 5,301 5.7%
Holding current value
$659,809
Previous $550,000 16.0%
% of portfolio
0.31%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$100.07 - $118.13 $30,221 - $35,675
302 Added 5.7%
5,603 $638,000
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $19,642 - $21,925
195 Added 3.82%
5,301 $550,000
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $54,321 - $59,996
-496 Reduced 8.85%
5,106 $580,000
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $180 - $220
2 Added 0.04%
5,602 $616,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $534,968 - $641,872
5,600 New
5,600 $542,000
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $38,744 - $45,604
400 Added 9.76%
4,500 $455,000
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $28,518 - $33,456
300 Added 7.89%
4,100 $450,000
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $19,352 - $22,406
200 Added 5.56%
3,800 $367,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $30,620 - $37,011
300 Added 9.09%
3,600 $391,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $376,266 - $458,832
3,300 New
3,300 $390,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $228,070 - $252,312
-1,955 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $21,158 - $24,906
200 Added 11.4%
1,955 $227,000
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $191,014 - $225,043
1,755 New
1,755 $210,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Beta Wealth Group, Inc. Portfolio

Follow Beta Wealth Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beta Wealth Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beta Wealth Group, Inc. with notifications on news.